Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 2
1990 2
1991 2
1993 2
1998 2
1999 2
2000 3
2001 4
2002 7
2003 5
2004 7
2005 3
2006 13
2007 13
2008 8
2009 11
2010 17
2011 15
2012 18
2013 17
2014 14
2015 18
2016 13
2017 24
2018 19
2019 13
2020 17
2021 15
2022 8
2023 1

Text availability

Article attribute

Article type

Publication date

Search Results

271 results

Results by year

Filters applied: . Clear all
Page 1
Treatment-Related Adverse Events of PD-1 and PD-L1 Inhibitors in Clinical Trials: A Systematic Review and Meta-analysis.
Wang Y, Zhou S, Yang F, Qi X, Wang X, Guan X, Shen C, Duma N, Vera Aguilera J, Chintakuntlawar A, Price KA, Molina JR, Pagliaro LC, Halfdanarson TR, Grothey A, Markovic SN, Nowakowski GS, Ansell SM, Wang ML. Wang Y, et al. Among authors: markovic sn. JAMA Oncol. 2019 Jul 1;5(7):1008-1019. doi: 10.1001/jamaoncol.2019.0393. JAMA Oncol. 2019. PMID: 31021376 Free PMC article.
Diagnosis and Management of Waldenström Macroglobulinemia: Mayo Stratification of Macroglobulinemia and Risk-Adapted Therapy (mSMART) Guidelines 2016.
Kapoor P, Ansell SM, Fonseca R, Chanan-Khan A, Kyle RA, Kumar SK, Mikhael JR, Witzig TE, Mauermann M, Dispenzieri A, Ailawadhi S, Stewart AK, Lacy MQ, Thompson CA, Buadi FK, Dingli D, Morice WG, Go RS, Jevremovic D, Sher T, King RL, Braggio E, Novak A, Roy V, Ketterling RP, Greipp PT, Grogan M, Micallef IN, Bergsagel PL, Colgan JP, Leung N, Gonsalves WI, Lin Y, Inwards DJ, Hayman SR, Nowakowski GS, Johnston PB, Russell SJ, Markovic SN, Zeldenrust SR, Hwa YL, Lust JA, Porrata LF, Habermann TM, Rajkumar SV, Gertz MA, Reeder CB. Kapoor P, et al. Among authors: markovic sn. JAMA Oncol. 2017 Sep 1;3(9):1257-1265. doi: 10.1001/jamaoncol.2016.5763. JAMA Oncol. 2017. PMID: 28056114 Free PMC article. Review.
NKG7 Is a T-cell-Intrinsic Therapeutic Target for Improving Antitumor Cytotoxicity and Cancer Immunotherapy.
Wen T, Barham W, Li Y, Zhang H, Gicobi JK, Hirdler JB, Liu X, Ham H, Peterson Martinez KE, Lucien F, Lavoie RR, Li H, Correia C, Monie DD, An Z, Harrington SM, Wu X, Guo R, Dronca RS, Mansfield AS, Yan Y, Markovic SN, Park SS, Sun J, Qin H, Liu MC, Vasmatzis G, Billadeau DD, Dong H. Wen T, et al. Among authors: markovic sn. Cancer Immunol Res. 2022 Feb;10(2):162-181. doi: 10.1158/2326-6066.CIR-21-0539. Epub 2021 Dec 15. Cancer Immunol Res. 2022. PMID: 34911739 Free PMC article.
Metastatic malignant melanoma.
Markovic SN, Erickson LA, Flotte TJ, Kottschade LA, McWilliams RR, Jakub JW, Farley DR, Tran NV, Schild SE, Olivier KR, Vuk-Pavlovic S, Sekulic A, Weenig RH, Pulido JS, Quevedo JF, Vile RG, Wiseman GA, Stoian I, Pittelkow MR; Melanoma Study Group of the Mayo Clinic Cancer Center. Markovic SN, et al. G Ital Dermatol Venereol. 2009 Feb;144(1):1-26. G Ital Dermatol Venereol. 2009. PMID: 19218908 Review.
Long-term outcome of immunologic autograft engineering.
Porrata LF, Inwards DJ, Ansell SM, Micallef IN, Johnston PB, Villasboas JC, Paludo J, Markovic SN. Porrata LF, et al. Among authors: markovic sn. EJHaem. 2022 Feb 24;3(2):488-491. doi: 10.1002/jha2.404. eCollection 2022 May. EJHaem. 2022. PMID: 35846064 Free PMC article.
Nab-paclitaxel in patients with metastatic melanoma.
Leon-Ferre RA, Markovic SN. Leon-Ferre RA, et al. Among authors: markovic sn. Expert Rev Anticancer Ther. 2015;15(12):1371-7. doi: 10.1586/14737140.2015.1110024. Epub 2015 Nov 4. Expert Rev Anticancer Ther. 2015. PMID: 26536477 Review.
Combining Immune Checkpoint Inhibitors With Conventional Cancer Therapy.
Yan Y, Kumar AB, Finnes H, Markovic SN, Park S, Dronca RS, Dong H. Yan Y, et al. Among authors: markovic sn. Front Immunol. 2018 Jul 27;9:1739. doi: 10.3389/fimmu.2018.01739. eCollection 2018. Front Immunol. 2018. PMID: 30100909 Free PMC article. Review.
Emerging therapies for melanoma.
Katipamula R, Markovic SN. Katipamula R, et al. Among authors: markovic sn. Expert Rev Anticancer Ther. 2008 Apr;8(4):553-60. doi: 10.1586/14737140.8.4.553. Expert Rev Anticancer Ther. 2008. PMID: 18402522 Review.
Regional lymphatic immunity in melanoma.
Grotz TE, Mansfield AS, Jakub JW, Markovic SN. Grotz TE, et al. Among authors: markovic sn. Melanoma Res. 2012 Feb;22(1):9-18. doi: 10.1097/CMR.0b013e32834e1f33. Melanoma Res. 2012. PMID: 22082957 Review.
Merkel cell carcinoma of unknown primary: Clinical presentation and outcomes.
Broida SE, Chen XT, Baum CL, Brewer JD, Block MS, Jakub JW, Pockaj BA, Foote RL, Markovic SN, Hieken TJ, Houdek MT. Broida SE, et al. Among authors: markovic sn. J Surg Oncol. 2022 Nov;126(6):1080-1086. doi: 10.1002/jso.27010. Epub 2022 Jul 9. J Surg Oncol. 2022. PMID: 35809230 Review.
271 results